Biogen Inc vs Dominion Energy Inc — how do they compare? Biogen Inc trades at $190.26 (market cap $30.86B), while Dominion Energy Inc trades at $71.2 (market cap $62.27B). The key difference: Dominion Energy Inc is far larger — about 2× Biogen Inc's market cap, and Dominion Energy Inc pays a 3.77% dividend while Biogen Inc pays none. Which is the better fit depends on your goals.
| BIIB | D | |
|---|---|---|
Market Cap | $30.86B | $62.27B |
Sector | Health | Utilities |
52-Week High | $216.63 | $71.32 |
52-Week Low | $122.68 | $56.55 |
Enterprise Value | $33.14B | $114.67B |
Dividend Yield | — | 3.77% |
Trailing returns across standard periods
Latest headlines on both assets
Biogen and Idec merged in 2003, combining forces to market Biogen's multiple sclerosis drug Avonex and Idec's cancer drug Rituxan. Today, Rituxan and next-generation antibody Gazyva are marketed via a collaboration with Roche. Biogen also markets novel MS drugs Plegridy, Tysabri, Tecfidera, and Vumerity. In Japan, Biogen's MS portfolio is co-promoted by Eisai. Hemophilia therapies Eloctate and Alprolix (partnered with SOBI) were spun off as part of Bioverativ in 2017. Biogen has several drug candidates in phase 3 trials in neurology and neurodegenerative diseases and has launched Spinraza with partner Ionis. Aduhelm was approved as the firm's first Alzheimer's disease therapy in June 2021.
Read more on BIIB →Based in Richmond, Virginia, Dominion Energy is an integrated energy company with over 30 gigawatts of electric generation capacity and more than 90,000 miles of electric transmission and distribution lines. Dominion owns a liquefied natural gas export facility in Maryland and is constructing a 5.2 GW wind farm off the Virginia Beach coast.
Read more on D →